We demonstrate that miR-369-3p may ameliorate the inflammatory state of IBD patients by modulating the NLRP3 inflammasome complex, thereby suggesting potential new therapeutic approaches in intestinal inflammation. The gene discussed is NLRP3; the disease is inflammatory bowel disease.